SQ 20858
Code | Size | Price |
---|
TAR-T26212-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T26212-500mg | 500mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Images
Documents
Further Information
Bioactivity:
SQ 20858 is a synthetic peptide derived from snake Bothrops jararaca venom; suppresses angiotensin serum converting enzyme.
CAS:
35115-62-9
Molecular Weight:
1196.31
Purity:
0.98
SMILES:
C([C@@H](C(=O)N1[C@H](C(N[C@H](C(=O)N2[C@H](C(N[C@H](C(N[C@H](C(=O)N3[C@H](C(=O)N4[C@H](C(O)=O)CCC4)CCC3)[C@H](CC)C)=O)CCC(N)=O)=O)CCC2)CC5=CN=CN5)=O)CCC1)NC([C@@H](NC(=O)[C@@H]6CCC(=O)N6)CC(N)=O)=O)C=7C=8C(NC7)=CC=CC8
References
Loyke HF. The inhibition of angiotensin converting enzyme in chronic renal hypertension by a synthetic peptide. Proc Soc Exp Biol Med. 1975 Nov;150(2):457-60. PubMed PMID: 174133.